Kimia Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 950.2 million compared to INR 967.01 million a year ago. Revenue was INR 957.34 million compared to INR 986.86 million a year ago. Net loss was INR 22.95 million compared to net income of INR 60.11 million a year ago. Basic loss per share from continuing operations was INR 0.49 compared to basic earnings per share from continuing operations of INR 1.27 a year ago. Diluted loss per share from continuing operations was INR 0.49 compared to diluted earnings per share from continuing operations of INR 1.27 a year ago.